Working Group Meetings |
|||
| Thursday, March 28, 2019 |
|||
| Room 1: Erechthion Suite (level 1) |
Room 2: Themistocles (level -1) |
Room 3: Aristotelis B (ground floor) |
|
| 12:00 - 13:00 | NETWORKING / LUNCH |
||
| 13:00 - 14:00 | Allergy | Adherence | |
| 14:00 - 15:00 | Technologies | ||
| 15:00 - 16:00 | Chronic Cough | Biomarkers & Severe asthma | |
| 16:00 - 16:30 | Coffee Break | ||
| 16:30 - 17:30 | Database & Coding | Small Airways / Non Severe Asthma | |
| 17:30 - 18:30 | Cost Effectiveness | COPD | ILD/IPF |
| 18:30 - 19:30 |
ACO | ILD/IPF | |
| Friday, March 29, 2019 |
|
| Plenary Room |
|
| 19:00 - 19:30 |
Child health |
Scientific Agenda |
| Friday, March 29, 2019 | |||
| 08:50 - 09:00 | Welcome, Prof. Nikos Papadopoulos | ||
| 09:00 - 10:30 | COPD: Should Patients with Severe COPD be Treated with ICS? Chair: Dr. Alan Kaplan Pro: Prof. Alberto Papi Con: Prof. Marc Miravitlles |
Pro and Con | |
| 10:30 - 11:00 | Coffee break | ||
| 11:00 - 12:00 | Role of Immunotherapy in Asthma: Chair: Prof. Moises Calderon - Allergen exposure studies in the ECC for Asthma, Prof Frederic de Blay - Responders and non-responders to AIT for asthma, Prof. Carmen Vidal - Immunotherapy versus Biologicals, Prof. Nikos Papadopoulos |
||
| 12:00 - 12:30 | Maximizing the First International Severe Asthma registry for Research Introduction, Prof. Giorgio Walter Canonica & Prof. David Price Research agenda, Prof. Chin Kook Rhee & Prof. Andrew Menzies-Gow New tools, Dr. Rupert Jones & Dr. Luis Pérez-de-Llano |
||
| 12:30 - 13:30 | Lunch break | ||
| 13:30 - 14:00 |
IPF: Does Early Treatment Make a Difference? Chair: Prof. Mark Jones Prof. Kevin Flaherty |
||
| 14:00 - 15:00 | New Paradigms in Mild Asthma: Regular ICS therapy is better than prn ICS/LABA in mild asthma? Chair: Dr. Alan Kaplan Pro: Prof. Ken Chapman Con: Prof. Mark Fitzgerald |
Pro and Con | |
| 15:00 - 15:30 |
Coffee break | ||
| 15:30 - 17:00 | Controversies in Pediatric Asthma: Chair: Prof. Nikos Papadopoulos |
||
| The term “preschool wheeze” should be abandoned? Pro: Prof. Adnan Custovic Con: Prof. Steve Turner |
Pro and Con | ||
| The limits and distribution of asthma severity in kids: where should we draw the line? Prof. Francine Ducharme |
|||
| Next-generation Guidelines: are phenotype/endotype-based recommendations feasible/preferable? Pro: Prof. Antonio Nieto Con: Prof. Clare Murray |
Pro and Con |
||
| 17:00 - 17:40 | Treatable Traits Chair: Joan Soriano & Dermot Ryan Prof. Nicolas Roche - Specialist Prof. Rupert Jones - GP |
||
| 17:40-18:10 | Inhaler Technique and Adherence Chair: Prof. Sinthia Bosnic-Anticevich Prof. Janwillem Kocks |
||
| Saturday, March 30, 2019 | ||
| 09:00 - 09:30 | Vaccinating Your Respiratory Patient Chair: Prof. Antonio Anzueto Dr. Alan Kaplan |
|
| 09:30 - 11:30 | Severe Asthma: The Evolving Algorithm of Biological Selection in Severe Asthma Creating and Algorithm for Care Chair: Prof. Mark Fitzgerald, Prof. Nikos Papadopoulos 1. Severe asthma overview, Prof. Mina Gaga 2. No biologic treatment, Prof. Peter Barnes 3. Treatment with anti-IL5, Prof. Liam Heaney 4. Treatment with anti-IgE, Prof. Andrew Menzies-Gow 5. Treatment with anti IL4/13, Prof. Walter Canonica |
Panel Discussion |
| 11:30 - 12:00 | Coffee break | |
| 12:00 - 13:00 |
Keynote: Real-life research and its role in the future Chair: Prof. Mina Gaga Prof. Jean Bousquet |
|
| 13:00 | Meeting close |
|
